Mutagenesis, Vol. 17, No. 1, 37-43,
January 2002
© 2002 UK Environmental Mutagen Society/Oxford University Press
High throughput Comet assay using 96-well plates
Novartis Pharma AG, Genetic and Experimental Toxicology, WSH2881.5.14, CH-4002 Basel, Switzerland 1 Present address: School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK
The single-cell gel electrophoresis or Comet assay is becoming established as an industrial genotoxicity screening test. The aim of this study was to increase the throughput of compounds tested and to minimize the amount of test compound needed for an assay. We modified practical aspects of our standard protocol and designed an experimental procedure suitable for use with 96-well plates. By using a suspension culture rather than attached cells, the modified protocol enabled parallel testing of four compounds on a single microplate (10 duplicate concentrations per compound). A significant reduction in work time was achieved by replacing the previously used Trypan blue dye exclusion (TBDE) test by an automated measurement of ATP levels as the concurrent viability test. The rapid and easy to perform ATP test was carried out towards the end of the 3 h treatment. In this way we were able to select for further analysis and slide preparation only those concentrations which induced the desired range of cytotoxicity. The suitability of the modified test conditions and reproducibility of test results was demonstrated by results obtained with standard mutagens and eight drug candidates tested at various concentrations. In each case the results obtained with the standard and the modified protocols were comparable. By introducing the changes to our standard protocol, combined with automated image analysis, we were able to more than double our previous throughput.
2 To whom correspondence should be addressed. Tel: +41 61 32 41951; Fax: +41 61 32 41274; Email: andreas.hartmann{at}pharma.novartis.com
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. W. Knight, L. Birrell, and R. M. Walmsley Development and Validation of a Higher Throughput Screening Approach to Genotoxicity Testing Using the GADD45a-GFP GreenScreen HC Assay J Biomol Screen, January 1, 2009; 14(1): 16 - 30. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Witte, U. Plappert, H. de Wall, and A. Hartmann Genetic Toxicity Assessment: Employing the Best Science for Human Safety Evaluation Part III: The Comet Assay as an Alternative to In Vitro Clastogenicity Tests for Early Drug Candidate Selection Toxicol. Sci., May 1, 2007; 97(1): 21 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hartmann, M. Schumacher, U. Plappert-Helbig, P. Lowe, W. Suter, and L. Mueller Use of the alkaline in vivo Comet assay for mechanistic genotoxicity investigations Mutagenesis, January 1, 2004; 19(1): 51 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hartmann, E. Agurell, C. Beevers, S. Brendler-Schwaab, B. Burlinson, P. Clay, A. Collins, A. Smith, G. Speit, V. Thybaud, et al. Recommendations for conducting the in vivo alkaline Comet assay Mutagenesis, January 1, 2003; 18(1): 45 - 51. [Abstract] [Full Text] [PDF]
|
|